Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-11

FDA Approved: FLUVASTATIN SODIUM — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic version of fluvastatin sodium through an Original Application (ANDA) by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvastatin sodium (Fluvastatin sodium)

Snippet

ORIG AP for FLUVASTATIN SODIUM (FLUVASTATIN)